Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no patient-facing Mounjaro training course in the UK. Mounjaro (tirzepatide) is a prescription-only medicine, and the clinical knowledge required to prescribe, dispense or supervise it sits firmly with registered healthcare professionals — not with the people who take it. What you need as a patient is straightforward: a clinical assessment and clear guidance from your prescriber. The rest of this page explains what Mounjaro training actually refers to, who it is for, and what patients genuinely need to do before starting treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This comes up often, and it is understandable. Injecting yourself for the first time feels like something that ought to require formal instruction. It does require instruction, but not a course you enrol on. When tirzepatide is prescribed through a regulated UK pharmacy, the clinical team explains injection technique, site rotation (abdomen, thigh or upper arm), how to store your KwikPen correctly, and what to do if you miss a dose. That guidance comes from your prescriber and from the Patient Information Leaflet that arrives with every pen. The NHS medicines guidance on tirzepatide covers the same practical points in plain language. You do not need a certificate to start; you need a clinical green light.
Some companies do advertise "Mounjaro training courses" broadly, and if you want to understand what a Mounjaro training course online free typically contains and who it is genuinely aimed at, a quick look at the regulatory language and target audience tells you most of what you need to know: look for whether the provider is GPhC or NMC registered, and if the marketing targets the general public rather than regulated clinicians, treat it with caution.
Structured tirzepatide training programmes exist for a real purpose, they are built for prescribers, pharmacists, practice nurses and other regulated clinicians who are adding weight management to their clinical scope. These programmes typically cover the pharmacology of the dual GIP and GLP-1 mechanism, NICE eligibility criteria under TA1026, titration pathways, contraindications, managing side effects and the wraparound care requirements the NHS expects. They are accredited through professional bodies such as the Royal Pharmaceutical Society or equivalent, and completion feeds into continuing professional development records. Detailed information on what those programmes cover, and how they differ from general GLP-1 education, is set out on our healthcare professional training page. If you are a clinician looking to prescribe tirzepatide, that is the right starting point. If you are a patient, keep reading.
Rather than a training course, patients benefit from three practical things: a thorough clinical assessment before starting, clear written guidance on injection technique and storage from their prescriber, and access to a clinical team when questions come up during treatment. At nume, a GPhC-registered Independent Prescriber reviews every consultation personally, your answers do not go through a scoring algorithm. That review happens the same day, and the aftercare team is available seven days a week afterwards. Mounjaro is licensed for adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition; lower thresholds can apply for some ethnic backgrounds under UK guidance. BMI alone does not determine suitability, the prescriber assesses the full picture, including any medicines you take and any relevant medical history. For a sense of what that assessment involves, our overview of what a Mounjaro clinical pathway looks like walks through each stage plainly.
A separate meaning of "training" is also worth addressing here: many people ask whether exercise (specifically resistance or weight training) should be part of a tirzepatide programme. The evidence is clear that physical activity supports the outcomes of any weight management treatment, and that preserving muscle mass during significant weight loss matters for long-term metabolic health. Our page on Mounjaro and weight training covers what the research suggests and how to approach the conversation with your prescriber. The short answer is yes, strength-based activity is worth including, but your specific routine is something to agree with your clinical team rather than take from a generic plan. On the question of cost, the Mounjaro price comparison page sets out what a private prescription typically involves in the UK, so you can weigh up your options with accurate numbers. If you are ready to find out whether tirzepatide suits your situation, check your eligibility with our prescribers, no waiting list, no referral needed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.